Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ginkgo Bioworks Holdings Inc (DNA) vs GXO Logistics Inc (GXO) Price & Performance

Ginkgo Bioworks Holdings IncTrade
GXO Logistics IncTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs GXO Logistics Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.12 (market cap $590.53M), while GXO Logistics Inc trades at $51.45 (market cap $5.71B). The key difference: GXO Logistics Inc is far larger — about 9.7× Ginkgo Bioworks Holdings Inc's market cap. Which is the better fit depends on your goals.

DNAGXO
Market Cap
$590.53M$5.71B
Sector
HealthIndustrials
52-Week High
$16.14$65.59
52-Week Low
$5.48$45.52
Enterprise Value
$627.78M$10.88B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.

The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.

GXO Logistics Inc

GXO Logistics trades at $48.99, down 3.2% today, with a bearish technical outlook despite strong analyst support. The company shows solid revenue growth with Q1 2026 earnings beating expectations at $0.50 per share versus $0.37 expected. Recent partnerships with major retailers and expansion in Europe highlight business momentum, though thin profit margins and competitive pressures from Amazon pose challenges.

Wall Street remains bullish with 16 buy ratings and a $69.33 price target suggesting 41% upside. However, technical indicators signal near-term weakness, and the stock faces execution risks in maintaining growth against industry competition. The upcoming Q2 earnings on August 5 will be critical for validating the positive fundamental trajectory.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA

About GXO Logistics Inc

GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.

Read more on GXO